Context Therapeutics所有资讯

Context Therapeutics | SC 13G：超过5%持股股东披露文件-Avidity Partners Management LP(9.9%),Avidity Partners Management (GP) LLC(9.9%)等

05/13 10:39 (美东)

Context Therapeutics | SC 13G：超过5%持股股东披露文件-Deep Track Capital, LP(9.89%),Deep Track Biotechnology Master Fund, Ltd.(9.89%)等

05/10 16:07 (美东)

Context Therapeutics | 4：持股变动声明-高管 Minai-Azary Jennifer Lynn

03/22 08:07 (美东)

Context Therapeutics | 4：持股变动声明-高管 Levit Alex C.

03/22 08:07 (美东)

Context Therapeutics | 4：持股变动声明-高管 Lehr Martin A.

03/22 08:02 (美东)

Context Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Affinity Healthcare Fund, LP (EIN(2.06%),Affinity Asset Advisors, LLC (EIN(2.06%)

02/13 16:51 (美东)

Context Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Martin Lehr(8.8%),Martin Lehr 2000 Trust(5.1%)等

02/07 16:27 (美东)

Context Therapeutics | SC 13G：超过5%持股股东披露文件-Opaleye Management Inc.(5.14%)

01/05 00:00 (美东)

Context Therapeutics | 4：持股变动声明-董事 Kantoff Philip W.

2023/05/31 16:53 (美东)

Context Therapeutics | 4：持股变动声明-董事 West Linda

2023/05/31 16:53 (美东)

Context Therapeutics | 4：持股变动声明-董事 Stacey Jennifer Evans

2023/05/31 16:53 (美东)

Context Therapeutics | 4：持股变动声明-董事 BERMAN RICHARD J

2023/05/31 16:52 (美东)

Context Therapeutics | 4：持股变动声明

2023/02/21 20:05 (美东)

Context Therapeutics | 4：持股变动声明

2023/02/14 17:04 (美东)

Context Therapeutics | 4：持股变动声明

2023/02/14 17:04 (美东)

Context Therapeutics | 4：持股变动声明

2023/02/14 17:04 (美东)

Context Therapeutics | SC 13G：超过5%持股股东披露文件-Martin Lehr(7.3%),Martin Lehr 2000 Trust(5.1%)等

2023/02/14 16:03 (美东)

Context Therapeutics | 4：持股变动声明

2023/02/13 16:03 (美东)

Context Therapeutics | 4：持股变动声明

2023/02/06 16:03 (美东)

Context Therapeutics | 4：持股变动声明

2023/01/30 16:03 (美东)